Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Sapir Alex
Relationship:  
City:   Durham
State:   NC
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   94,019    

Indirect Shares

  21,700      
Direct Value   $1,315,328    

Indirect Value

  $608,468      
Total Shares   115,719      
Total Value   $1,923,796      


Dova Pharmaceuticals, Inc.
 $1,315,328 Phasebio Pharmaceuticals Inc
 $0 Fulcrum Therapeutics, Inc.
 $0 Dova Pharmaceuticals, Inc.
 $1,315,328 Phasebio Pharmaceuticals Inc
 $0 Fulcrum Therapeutics, Inc.
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Dova Pharmaceuticals, Inc. DOVA President & CEO, Direc... 2018-08-14 46,909 2018-08-14 21,700    Premium*  
            Phasebio Pharmaceuticals Inc PHAS Director 2023-05-19 3,750 2023-05-19 0    Premium*  
            Fulcrum Therapeutics, Inc. FULC 2024-03-04 43,360 2024-03-04 0    Premium*  
* Premium Members only  

Records found :    5         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
FULC Fulcrum Therapeutics, Inc... See Remarks   •       •      –    2024-03-04 4 B $11.35 $492,028 D/D 43,360 43,360 0.01 -
PHAS Phasebio Pharmaceuticals ... Director   –       •      –    2023-05-19 4 OE $0.00 $0 D/D 3,750 3,750 0 -
DOVA Dova Pharmaceuticals, Inc... President & CEO   •       •      –    2018-08-14 4 B $22.83 $495,411 I/I 21,700 21,700 2.66 -
DOVA Dova Pharmaceuticals, Inc... President & CEO   •       •      –    2017-12-22 4 OE $3.73 $99,998 D/D 26,809 46,909 0 -
DOVA Dova Pharmaceuticals, Inc... President & CEO   •       •      –    2017-07-05 4 B $17.00 $341,700 D/D 20,100 20,100 2.81 -

  5  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed